GlassScriptPhysician profile
Mary J Kippa
NPI 1396740437
$1,328.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $890 · 2022: $272 · 2023: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $878.42 | 2021-2023 | |
| Tactile Systems Technology INC | $63.91 | 2021-2022 | |
| Puma Biotechnology, INC. | $57.12 | 2021-2022 | |
| Incyte Corporation | $46.84 | 2022 | |
| Astellas Pharma US INC | $37.26 | 2022 | |
| Celgene Corporation | $34.39 | 2021-2022 | |
| Epizyme, INC. | $31.24 | 2021-2022 | |
| Medtronic, INC. | $25.96 | 2021-2022 | |
| Gilead Sciences, INC. | $24.86 | 2022 | |
| Myriad Genetic Laboratories, INC. | $21.77 | 2022 | |
| Dova Pharmaceuticals | $20.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.07 | 2021 | |
| Amgen INC. | $19.61 | 2021 | |
| Blueprint Medicines Corporation | $16.53 | 2022 | |
| Pfizer INC. | $16.49 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.94 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Kippa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.